Test Price
2,800 AED✅ Home Collection Available
RARS Gene Leukodystrophy Hypomyelinating Type 9 Genetic Test in UAE | 2,800 AED | DHA Licensed
Executive Summary & Core Metrics
This advanced genetic test targets the RARS gene responsible for Hypomyelinating Leukodystrophy Type 9 (HLD9) and employs Next‑Generation Sequencing (NGS) to deliver a definitive molecular diagnosis with 99.9% diagnostic sensitivity. All processing occurs within ISO 9001:2015 certified laboratories operating under strict DHA and MOHAP protocols, ensuring the highest clinical accuracy and patient data confidentiality. A pre‑test genetic counselling session is strongly recommended to construct a three‑generation pedigree chart and collect the clinical history of the affected individual.
- Accuracy Guarantee: 99.9% diagnostic sensitivity via ISO accredited processing.
- Premium Logistics: VIP Mobile Phlebotomy & Temperature‑Controlled Cold‑Chain Home Collection, available daily from 8 AM to 11 PM.
- Clinical Guidance: Telephonic post‑test clinical guidance for result interpretation and family variant testing.
- Insurance: Direct billing verification via WhatsApp +971 54 548 8731.
Test Overview & Methodology
The RARS Gene Leukodystrophy Hypomyelinating Type 9 Genetic Test detects pathogenic variants in the RARS gene, enabling precise diagnosis of hypomyelinating leukodystrophy type 9 (HLD9), a severe neurodegenerative disorder. Using Next‑Generation Sequencing (NGS) with full gene coverage, this assay provides the highest analytical sensitivity for confirming the genetic aetiology and supports early therapeutic planning. A genetic counselling session to draw a detailed pedigree of affected family members is strongly recommended before sample submission.
| Feature | Our RARS NGS Test | Closest Alternative (Whole Exome Sequencing) |
|---|---|---|
| Precision | Targeted NGS for RARS gene – >99.9% analytical sensitivity | Broad exome capture – lower specific sensitivity for RARS |
| Methodology | Next Generation Sequencing (NGS) with full gene coverage | Whole Exome Sequencing (WES) + bioinformatic filtering |
| Turnaround Time | 3–4 Weeks | 6–12 Weeks typical |
| Clinical Focus | Directly confirms HLD9; enables family variant testing | Incidental findings possible; less dedicated interpretation |
Physician Insight & Safety Protocols
“A positive RARS result must always be correlated with clinical presentation and neuroimaging. Genetic findings alone do not define the full prognosis; empathetic counselling and a multidisciplinary care plan are essential for the child and family.” — Lina Osama Zaki Quteineh, Consultant Medical Genetics (DHA: 9294403)
Clinical Advisory Notice
Important Safety Information
Never discontinue or alter any prescribed medication without explicit instruction from your neurologist or managing physician.
Exclusion Criteria & Red Flags
- Acute neurological deterioration or loss of consciousness—seek immediate emergency care.
- Severe respiratory distress or inability to protect airway—call 998.
- Recent blood transfusion or allogeneic stem cell transplant may interfere with germline NGS results; notify the laboratory.
Patient FAQ & Clinical Guidance
1. What does the RARS gene test detect?
This NGS test identifies pathogenic variants in the RARS gene causing hypomyelinating leukodystrophy type 9, enabling early intervention and genetic counselling. It provides a definitive molecular diagnosis for affected individuals and clarifies carrier status in unaffected family members.
2. Can the test be performed on children?
Yes, the RARS gene test is suitable for children and requires a venous blood sample or a dried blood spot on an FTA card. Parental consent and pre‑test genetic counselling are mandatory before sample collection.
3. What is the cost and how does insurance work?
The test costs 2,800 AED. Our support team verifies direct billing eligibility with your insurer via WhatsApp +971 54 548 8731. Simply send your Emirates ID and insurance card; we handle pre‑approvals before sample collection, eliminating upfront payment stress.
UAE Regulatory & Data Privacy Adherence
Data Protection & Legal Framework
All genetic data is processed in full compliance with Federal Decree-Law No. 45 of 2021 on Personal Data Protection (PDPL) and Federal Law No. 2 of 2019 Concerning the Use of Information and Communication Technology in Health Fields. Clinical safety and patient consent procedures adhere to Federal Decree-Law No. 4 of 2016 on Medical Liability. DNA Labs UAE holds DHA Facility License No. 1143 and operates under ISO 9001:2015 (Cert: INT/EGQ/2509DA/3139).
Clinical & Logistical Metadata
| Test Name | RARS Gene Leukodystrophy Hypomyelinating Type 9 Genetic Test |
| Price (AED) | 2,800 AED |
| Turnaround Time | 3–4 Weeks |
| Sample Type / Matrix | Whole Blood, Extracted DNA, or Dried Blood Spot on FTA Card |
| Methodology Used | Next Generation Sequencing (NGS) with full gene coverage |
| ICD-10-CM Code | E75.2 |
| LOINC Code | 21665-7 |
| DHA Facility License & Address | License: 1143 | Premises 105, Floor 1, Building 33, Dubai Healthcare City, Dubai, UAE | DNA Labs UAE |
دعم ثنائي اللغة متاح
التحقق من التغطية التأمينية
Check Insurance Coverage Instantly
Stop the guesswork. Send a photo of your Insurance Card and Doctor's Prescription to our DHA-Certified Verification Team on WhatsApp.
توقف عن التخمين. أرسل صورة من بطاقة التأمين ووصفة الطبيب إلى فريق التحقق المعتمد من هيئة الصحة بدبي عبر الواتساب. احصل على تحديث الحالة في دقائق.
Available in Arabic, English, Hindi & Urdu
ISMS 27001:2022
ISO Accredited
HIPAA
All reports reviewed by DHA-Certified physicians